1
/
of
1
AntibodySystem
SKU:DHD80999
Brentuximab vedotin (ADC)
Brentuximab vedotin (ADC)
Regular price
$4,510.00 USD
Regular price
Sale price
$4,510.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Catalog No.: DHD80999
| Catalog No. | DHD80999 |
|---|---|
| Product name | Brentuximab vedotin (ADC) |
| Size | 5 mg |
| Species reactivity | Human |
| Applications | Research Grade Biosimilar |
| Description | Brentuximab vedotin is an ADC consisting of a CD30-directed antibody and Monomethyl auristatin E (MMAE) that inhibits CD30-positive cells and is used for the study of relapsed and refractory Hogkin's lymphoma. |
| Form | Liquid |
| Purity | >90% as determined by SEC. |
| Clonality | Monoclonal |
| Target | CD30 |
| Purification | Purified by Ion Exchange Chromatography. |
| Endotoxin level | Please contact with the lab for this information. |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term. |
| Alternative Names | cAC10-vcMMAE |
| Clone ID | Brentuximab vedotin |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
Share
